Industry Should Encourage Clinical Trial Reform In China – Shanghai R&D Panel

SHANGHAI - The pharmaceutical industry should take advantage of China's desire to become a destination of choice for global clinical trials to encourage streamlining of regulatory requirements and expansion of clinical study sites, according to an April 1 panel discussion during the China 2008 Pharmaceutical R&D Summit in Shanghai